Research Article

Efficacy of Surgery in Patients with Stage I Primary Parotid Gland Lymphoma: A Population-Based Study

Table 2

Comparison of baseline data after PSM.

CharacteristicsLevelOverallNo surgerySurgery
464232232

Age (%)≤65251 (54.1)116 (50.0)135 (58.2)0.094
>65213 (45.9)116 (50.0)97 (41.8)

Sex (%)Female292 (62.9)143 (61.6)149 (64.2)0.631
Male172 (37.1)89 (38.4)83 (35.8)

Race (%)White386 (83.2)193 (83.2)193 (83.2)0.261
Black49 (10.6)21 (9.1)28 (12.1)
Other29 (6.2)18 (7.8)11 (4.7)

Marital status (%)No married222 (47.8)106 (45.7)116 (50.0)0.403
Married242 (52.2)126 (54.3)116 (50.0)

Year of diagnosis (%)1998–2003107 (23.1)54 (23.3)53 (22.8)0.412
2004–2009156 (33.6)84 (36.2)72 (31.0)
2010–2015201 (43.3)94 (40.5)107 (46.1)

Histology (%)MALT195 (42.0)96 (41.4)99 (42.7)0.046
DLBCL97 (20.9)55 (23.7)42 (18.1)
FL95 (20.5)37 (15.9)58 (25.0)
Other77 (16.6)44 (19.0)33 (14.2)

Laterality (%)Right213 (45.9)107 (46.1)106 (45.7)0.249
Left237 (51.1)115 (49.6)122 (52.6)
Bilateral14 (3.0)10 (4.3)4 (1.7)

Radiation (%)No251 (54.1)126 (54.3)125 (53.9)1.000
Yes213 (45.9)106 (45.7)107 (46.1)

Chemotherapy (%)No312 (67.2)155 (66.8)157 (67.7)0.921
Yes152 (32.8)77 (33.2)75 (32.3)

CI: confident interval and HR: hazard ratio.